SE350498B - - Google Patents

Info

Publication number
SE350498B
SE350498B SE13373/69A SE1337369A SE350498B SE 350498 B SE350498 B SE 350498B SE 13373/69 A SE13373/69 A SE 13373/69A SE 1337369 A SE1337369 A SE 1337369A SE 350498 B SE350498 B SE 350498B
Authority
SE
Sweden
Application number
SE13373/69A
Inventor
G Regnier
R Canevari
M Laubie
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE350498B publication Critical patent/SE350498B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE13373/69A 1968-10-02 1969-09-29 SE350498B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4680268 1968-10-02

Publications (1)

Publication Number Publication Date
SE350498B true SE350498B (pt) 1972-10-30

Family

ID=10442653

Family Applications (1)

Application Number Title Priority Date Filing Date
SE13373/69A SE350498B (pt) 1968-10-02 1969-09-29

Country Status (14)

Country Link
US (1) US3647794A (pt)
AT (1) AT291271B (pt)
BE (1) BE739283A (pt)
BR (1) BR6912898D0 (pt)
CH (1) CH517754A (pt)
DK (1) DK129656B (pt)
ES (1) ES371943A1 (pt)
FI (1) FI49512C (pt)
FR (1) FR2019646B1 (pt)
GB (1) GB1256513A (pt)
IE (1) IE33821B1 (pt)
NL (1) NL142681B (pt)
NO (1) NO124996B (pt)
SE (1) SE350498B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7103449A (pt) * 1971-03-15 1972-09-19
GR74944B (pt) * 1980-07-02 1984-07-12 Merck & Co Inc
FR2488509A1 (fr) * 1980-08-18 1982-02-19 Science Union & Cie Nouvelles compositions pharmaceutiques contenant de l'almitrine
FR2521560A1 (fr) * 1982-02-17 1983-08-19 Adir Nouveaux derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2525597B1 (fr) * 1982-04-21 1985-06-07 Adir Polymethylene diamines n,n'-substituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
FR2667243B1 (fr) * 1990-09-27 1994-11-04 Adir Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
HU214331B (hu) * 1992-06-17 1998-03-02 Gyógyszerkutató Intézet Kft. Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
RU2020105742A (ru) 2017-07-13 2021-08-13 Майкл Девид ФОРРЕСТ Терапевтические модуляторы обратного режима атф-синтазы
WO2021186325A1 (en) 2020-03-15 2021-09-23 Forrest Michael David Almitrine for treating the hypoxemia of a coronavirus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB946309A (en) * 1959-09-02 1964-01-08 Upjohn Co Therapeutic gastric anti-secretory composition
DE1620528A1 (de) * 1965-12-31 1970-06-11 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen basisch substituierten s-Triazinen

Also Published As

Publication number Publication date
GB1256513A (pt) 1971-12-08
IE33821B1 (en) 1974-11-13
FI49512C (fi) 1975-07-10
BE739283A (pt) 1970-03-23
BR6912898D0 (pt) 1973-05-24
FR2019646B1 (pt) 1973-08-10
US3647794A (en) 1972-03-07
IE33821L (en) 1970-04-02
NL6914749A (pt) 1970-04-06
AT291271B (de) 1971-07-12
CH517754A (fr) 1972-01-15
DE1947332A1 (de) 1970-04-09
FR2019646A1 (pt) 1970-07-03
NL142681B (nl) 1974-07-15
DK129656C (pt) 1975-04-07
DK129656B (da) 1974-11-04
ES371943A1 (es) 1971-11-16
FI49512B (pt) 1975-04-01
NO124996B (pt) 1972-07-03

Similar Documents

Publication Publication Date Title
AU5184069A (pt)
FR2019646B1 (pt)
AU6168869A (pt)
AU6171569A (pt)
AU2952567A (pt)
BE715867A (pt)
AU3224368A (pt)
BE716477A (pt)
BE709446A (pt)
BE726618A (pt)
BE726553A (pt)
BE726510A (pt)
BE726779A (pt)
BE726443A (pt)
BE726218A (pt)
BE725691A (pt)
BE722955A (pt)
BE722921A (pt)
BE721615A (pt)
BE709301A (pt)
BE726986A (pt)
BE715282A (pt)
BE709496A (pt)
BE709484A (pt)
BE709479A (pt)